Divalproex sodium
- Generic Name
- Divalproex sodium
Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Depakote
Manufacturer:AbbVie Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2024/03/27
NDC:0074-6215
Divalproex Sodium
Manufacturer:NCS HealthCare of KY, LLC dba Vangard Labs
Route:ORAL
Strength:500 mg in 1 1
Approved: 2023/09/19
NDC:0615-8328
Divalproex Sodium
Manufacturer:NCS HealthCare of KY, LLC dba Vangard Labs
Route:ORAL
Strength:125 mg in 1 1
Approved: 2023/09/19
NDC:0615-8326
Divalproex Sodium
Manufacturer:NCS HealthCare of KY, LLC dba Vangard Labs
Route:ORAL
Strength:250 mg in 1 1
Approved: 2023/09/19
NDC:0615-8327
Divalproex sodium
Manufacturer:Ajanta Pharma USA Inc.
Route:ORAL
Strength:125 mg in 1 1
Approved: 2023/04/19
NDC:27241-115
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath